Prolight Diagnostics has secured European patent approval for its method for separating plasma from whole blood, utilized in the MicroFlex system. This separation technology presents a business opportunity as it can be integrated into other systems and adapted for use with various sample types. To gain deeper insights into the technology, BioStock contacted the company’s development partner, TTP.
Read the full article at biostock.se:
https://www.biostock.se/en/2024/10/prolight-eyes-business-opportunity-for-plasma-separation-method/
This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se